Tag: OTC PINK:BMKDF

biomark-to-present-validation-data-of-its-multianalyte-metabolite-panel-for-lung-cancer-screening-at-the-esmo-congress-2022

BioMark to Present Validation Data of Its Multianalyte Metabolite Panel for Lung Cancer Screening at the ESMO Congress 2022

Vancouver, British Columbia–(Newsfile Corp. – September 8, 2022) – BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark”) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce ...

biomark-selected-by-the-medical-alley-and-investissement-quebec-to-join-the-us-go-to-market-accelerator

BioMark Selected by the Medical Alley and Investissement Quebec to Join the Us Go-To-Market Accelerator

Vancouver, British Columbia–(Newsfile Corp. – September 1, 2022) – BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark”) an oncology-focused company with advanced near-to-market liquid biopsy diagnostic technologies is pleased to announce today that its Quebec-based wholly-owned subsidiary ...